Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $1,700,000 Small Business Innovation Research (SBIR) grant to advance Zylö’s proprietary nitric-oxide-releasing topical drug candidate into clinical trials. Read more >>
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, has announced a partnership with Dr. Rod Walters,…
read moreSkyline Medical Inc. (NASDAQ: SKLN) announces that it has received a Medical Device Establishment License to sell the STREAMWAY…
read moreSue Nolin VP, Inside Sales, Wasabi Technologies — When it comes to growing sales and its channel team, Wasabi…
read morePayton Crum wears her new eSight electronic glasses during a music lesson. The 7-year-old is legally blind. Read more…
read moreResearch that began in San Antonio could soon produce a first-of-its-kind treatment for traumatic brain injuries, like concussions and…
read morePyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer…
read moreRegroup Mass Notification, trusted provider of emergency and day-to-day mass notification solutions, today announced that its mobile application, AlertMe,…
read morePixability, the leading provider of insights and optimizations for video advertising across YouTube, Facebook, and Connected TV, announced a…
read moreThe Maryland biotech startup is developing new treatments for Parkinson’s disease and Alzheimer’s disease. Read more >>
read moreHematologic malignancies are cancers that affect the blood, bone marrow and lymph nodes and include different forms of leukemia…
read more